Osteoporosis is a common disease that affects millions of patients througho
ut the world. We anticipate that both the diagnosis and the treatment of th
is disease will be revolutionized by the integration of genomics and inform
atics. It is predicted that a genetic algorithm will be developed to identi
fy at-risk patients before they develop osteoporosis, so that preventive me
asures can be instituted. The sequencing of the human genome will lead to r
evolutionary advances in at least three areas of osteoporosis therapy: smal
l molecule therapy, protein therapy and gene therapy. One area of focus for
future therapeutics in osteoporosis will be on osteogenic agents, which sh
ould have a high likelihood of success because the skeleton has the innate
capacity to regenerate itself.